Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

作者信息

Pietrosi Giada, Mandala Lucio, Vizzini Giovanni B, Gruttadauria Salvatore, Minervini Marta I, Burgio Gaetano, Spadaro Aldo, Gridelli Bruno

出版信息

Transpl Int. 2008 May;21(5):502-4. doi: 10.1111/j.1432-2277.2007.00623.x. Epub 2007 Dec 19.

DOI:10.1111/j.1432-2277.2007.00623.x

PMID:18167153

Abstract

摘要

相似文献

Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?

Transpl Int. 2008 May;21(5):502-4. doi: 10.1111/j.1432-2277.2007.00623.x. Epub 2007 Dec 19.

Acute liver failure in a patient with multiple sclerosis treated with interferon-beta.

Mult Scler. 2007 Jul;13(6):820. doi: 10.1177/1352458506070893. Epub 2007 Feb 9.

[Appearance of immune thyroid diseases during beta-interferon therapy of multiple sclerosis].

Dtsch Med Wochenschr. 1999 Dec 3;124(48):1473.

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a.

Bone Marrow Transplant. 2004 Jul;34(2):187-8. doi: 10.1038/sj.bmt.1704550.

Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.

J Clin Pharm Ther. 2009 Feb;34(1):125-7. doi: 10.1111/j.1365-2710.2008.00983.x.

Liver injury associated with the beta-interferons for MS.

Neurology. 2004 Sep 28;63(6):1142-3; author reply 1142-3.

An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Intern Med. 2017;56(14):1897-1901. doi: 10.2169/internalmedicine.56.7980. Epub 2017 Jul 15.

Halo nevi associated with interferon beta-1a therapy.

Actas Dermosifiliogr. 2012 Jan;103(1):75-6. doi: 10.1016/j.adengl.2011.02.005. Epub 2012 Mar 24.

Fulminant liver failure during interferon beta treatment of multiple sclerosis.

Neurology. 2001 May 22;56(10):1416. doi: 10.1212/wnl.56.10.1416.

Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.

Neurology. 2006 Jun 27;66(12):1954-5. doi: 10.1212/01.wnl.0000219764.27182.c7.

引用本文的文献

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.

Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.

The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.

CNS Drugs. 2021 Aug;35(8):861-880. doi: 10.1007/s40263-021-00842-9. Epub 2021 Jul 28.

An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Intern Med. 2017;56(14):1897-1901. doi: 10.2169/internalmedicine.56.7980. Epub 2017 Jul 15.

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.

Dtsch Arztebl Int. 2016 Dec 26;113(51-52):879-886. doi: 10.3238/arztebl.2016.0879.

Presentation and outcomes with clinically apparent interferon beta hepatotoxicity.

Dig Dis Sci. 2013 Jun;58(6):1766-75. doi: 10.1007/s10620-012-2553-1. Epub 2013 Feb 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验